| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |